Pembrolizumab-Induced Pancreatic Exocrine Insufficiency Complicated by Severe Hepatic Steatosis

Anti-programmed death receptor-1 (anti-PD-1) monoclonal antibodies (mAbs) are used to treat an increasing range of cancers. However, the distinct toxicity profile of immune-related adverse events (irAEs) is a frequent drawback of their clinical application. Among the more common irAEs are hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Alex S, Sarwar, Naveed, Goldin, Robert D, Dhar, Ameet, Possamai, Lucia A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354921/
https://www.ncbi.nlm.nih.gov/pubmed/35936135
http://dx.doi.org/10.7759/cureus.26596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354921/
https://www.ncbi.nlm.nih.gov/pubmed/35936135
http://dx.doi.org/10.7759/cureus.26596

Ejemplares similares